KV

Kurt Vogtli

AA Aicuris Anti-Infective Cures Ag: 4 patents #3 of 48Top 7%
AK Aicuris Gmbh & Co. Kg: 2 patents #48 of 145Top 35%
AA Astrazeneca Ab: 1 patents #1,022 of 1,971Top 55%
Overall (All Time): #706,580 of 4,157,543Top 20%
7
Patents All Time

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
RE49697 Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations Wilfried Schwab, Alexander Birkmann, Kerstin Paulus, Dieter Haag, Stephan Maas +1 more 2023-10-17
10137117 Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations Wilfried Schwab, Alexander Birkmann, Kerstin Paulus, Dieter Haag, Stephan Maas +1 more 2018-11-27
9889124 Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations Wilfried Schwab, Alexander Birkmann, Kerstin Paulus, Dieter Haag, Stephan Maas +1 more 2018-02-13
9592225 Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations Wilfried Schwab, Alexander Birkmann, Kerstin Paulus, Dieter Haag, Stephan Maas +1 more 2017-03-14
9340535 N-[5-(Aminosulfony1)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate Wilfried Schwab, Alexander Birkmann, Dieter Haag, Andreas Lender, Alfons Grunenberg +2 more 2016-05-17
9119786 Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations Wilfried Schwab, Alexander Birkmann, Kerstin Paulus, Dieter Haag, Stephan Maas +1 more 2015-09-01
7960582 Process for the preparation and resolution of mandelic acid derivatives Hans Jorgen Blixt, Bo Lars Gustaf Bosson, Roberto Guiseppe Paolo Gatti, Simone Zaramella, Michael William Senior +1 more 2011-06-14